STATE, LEGITIMATE VIOLENCE AND ACTIVITIES OF PRIVATE MILITARY-SECURITY COMPANIES IN THE MODERN WORLD

Por D. O. Novikova
Publicado em 2015-07-01

ACCORDING TO THE MATERIALS OF THE 2015/2016 NEW EUROPEAN LEAGUE AGAINST RHEUMATISM (EULAR) GUIDELINES FOR REDUCING CARDIOVASCULAR RISK IN PATIENTS WITH INFLAMMATORY ARTHRITIS: GENE...

Por T. V. Popkova, D. S. Novikova
Publicado em 2018-07-01

COMBINED VACCINE IS AN EFFECTIVE AND SAFE PROTECTION FROM FIVE CONTROLLABLE INFECTIONS

Por D. A. Novikova, N. E. Tkachenko
Publicado em 2014-05-01

PROATHEROGENIC LIPID AND LIPOPROTEIN METABOLIC DISTURBANCES IN PATIENTS WITH RHEUMATOID ARTHRITIS

Por E. V. Gerasimova, T. V. Popkova, D. S. Novikova
Publicado em 2017-07-01

CARDIOVASCULAR DISEASES IN RHEUMATOID ARTHRITIS: LATEST DATA

Por T. V. Popkova, D. S. Novikova, E. L. Nasonov
Publicado em 2016-07-01

Rekomendatsii po snizheniyukardiovaskulyarnogo riska u patsientov s vospalitel'nymi artritami(po materialam rekomendatsiy Evropeyskoy antirevmaticheskoy ligi)

Por T V Popkova, D S Novikova, E L Nasonov
Publicado em 2010-03-01

NEW DATA ON THE SAFETY OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS: THE CONCEPT OF THE HIGH CLASS-SPECIFIC CARDIOVASCULAR RISK OF SELECTIVE CYCLOOXYGENASE-2 INHIBITORS IS OUTDATED

Por A. E. Karateev, D. S. Novikova, E. L. Nasonov
Publicado em 2017-04-01

Laboratory diagnosis of antiphospholipid syndrome

Por E N Alexandrova, A A Novikov, D S Novikova
Publicado em 2004-08-01

Ihmor necrosis factor-a inhibitors and cardiovascular risk in rheumatoid arthritis

Por Tatiana Valentinovna Popkova, D S Novikova, E L Nasonov
Publicado em 2012-12-01

Tumor necrosis factor-α inhibitors and their effects on cardiovascular risk factorsin patients with rheumatoid arthritis

Por O G Lineva, T V Popkova, D S Novikova, E L Nasonov, O G Lineva, T V Popkova, D S Novikova, E L Nasonov
Publicado em 2010-02-01

Arteries rigidity – integral index of cardiovascular risk in patients with rheumatoid arthritis

Por D S Novikova, T V Popkova, E S Mach, E L Nasonov
Publicado em 2009-10-01

Calcium evaluation in coronary arteries: new possibilities of cardiovascular complications risk stratification in patients with autoimmune diseases

Por D S Novikova, T V Popkova, E S Mach, E L Nasonov
Publicado em 2009-06-01

Chronic Heart Failure in Rheumatoid Arthritis Patients (Part II): Difficulties of Diagnosis

Por D. S. Novikova, H. V. Udachkina, I. G. Kirillova, T. V. Popkova
Publicado em 2019-01-01

Chronic Heart Failure in Rheumatoid Arthritis Patients (Part I): Prevalence, Etiology and Pathogenesis

Por D. S. Novikova, I. G. Kirillova, H. V. Udachkina, T. V. Popkova
Publicado em 2018-11-01

Dynamics of Carotid Intima-Media Thickness, Parameters of Arterial Stiffness and Ambulatory Blood Pressure Monitoring during Therapy with Inhibitor of Tumor Necrosis Factor-Alpha...

Por E. I. Markelova, D. S. Novikova, T. V. Korotaeva, E. Yu. Loginova
Publicado em 2018-11-01

Chronic Heart Failure in Rheumatoid Arthritis Patients (Part III): Effects of Antirheumatic Drugs

Por D. S. Novikova, H. V. Udachkina, I. G. Kirillova, T. V. Popkova
Publicado em 2020-01-01

Time course of changes in lipid profile measures in patients with early psoriatic arthritis during adalimumab therapy

Por E. I. Markelova, D. S. Novikova, T. V. Korotaeva, E. Yu. Loginova
Publicado em 2019-11-01

TRADITIONAL RISK FACTORS FOR CARDIOVASCULAR DISEASES IN SYSTEMIC SCLEROSIS AND THEIR RELATIONSHIP TO STRUCTURAL CHANGES OF THE HEART

Por E. O. Saad, L. P. Ananyeva, D. S. Novikova, R. T. Alekperov
Publicado em 2017-01-01

SIGNIFICANCE OF HEART RHYTHM VARIABILITY IN RHEUMATOID ARTHRITIS

Por E. V. Udachkina, D. S. Novikova, T. V. Popkova, E. L. Nasonov
Publicado em 2016-02-01

Role of interleukin-6 in the development of atherosclerosis in rheumatoid arthritis

Por Elena Vasilyevna Udachkina, D S Novikova, T V Popkova, E L Nasonov
Publicado em 2013-10-01